Arylsulfatase B controlled release (Hanmi Pharmaceutical)

N/A

Report date: 2024/11/05 16:40:42

Base Information

Drug NameArylsulfatase B controlled release (Hanmi Pharmaceutical)
Drug Alias NameHM-15450
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionArylsulfatase B stimulants
TargetsArylsulfatase B
Therapy Area/IndicationsMucopolysaccharidosis VI
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis VI
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A